Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Stem Cell Tourism Hardly a Vacation 

 

 

Stem Cell Tourism Hardly a Vacation

August 16, 2012 - (GEN) - "A July 23 federal court decision allows the agency to regulate as drugs clinical treatments produced from patients’ stem cells processed beyond “minimal” manipulation. The U.S. District Court in Washington, DC, upheld an FDA injunction shutting down Regenerative Sciences, contending its Regenexx-C stem-cell therapy entails more-than- “minimal” manipulation and is thus a drug requiring agency approval."  Read Full Article

 

Posted on 23-Aug-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: